Pharming Group Financial Overview
Pharming Group's market cap is currently $986.61M. The company's EPS TTM is €0.0085449855; its P/E ratio is -7,200.00; Pharming Group is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.
